✦ LIBER ✦

The treatment of Wilms' Tumor: Results of the second national Wilms' Tumor study

✍ Scribed by G. J. D'Angio; A. Evans; N. Breslow; B. Beckwith; H. Bishop; V. Farewell; W. Goodwin; L. Leape; N. Palmer; L. Sinks; W. Sutow; M. Tefft; J. Wolff

Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 934 KB
Volume: 47
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19810501)47:9<2302::aid-cncr2820470933>3.0.co;2-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors in nonmetastatic, fav

Prognostic factors in nonmetastatic, favorable histology wilms' tumor. Results of the third national wilms' tumor study

✍ Norman Breslow; Katrina Sharples; J. Bruce Beckwith; Janice Takashima; Panayotis 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 802 KB

Late effects of treatment for wilms' tum

Late effects of treatment for wilms' tumor. A report from the national wilms' tumor study group

✍ Audrey E. Evans; Patricia Norkool; Ilonka Evans; Norman Breslow; Giulio J. D'Ang 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Risk factors for Wilms tumor: Report fro

Risk factors for Wilms tumor: Report from the national Wilms tumor study

✍ Andrew F. Olshan; Norman E. Breslow; John M. Falletta; Seymour Grufferman; Thoma 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 607 KB

Wilms' tumor: Prognostic factors for pat

Wilms' tumor: Prognostic factors for patients without metastases at diagnosis. Results of the national Wilms' tumor study

✍ N. E. Breslow; N. F. Palmer; L. R. Hill; J. Buring; G. J. d'Angio 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 976 KB

Doxorubicin for favorable histology, Sta

Doxorubicin for favorable histology, Stage II–III Wilms tumor : Results from the National Wilms Tumor Studies

✍ Norman E. Breslow; San-San Ou; J. Bruce Beckwith; Gerald M. Haase; John A. Kalap 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract ## BACKGROUND After randomized trials in the 1980s, doxorubicin (DOX) was added to dactinomycin plus vincristine as standard chemotherapy for patients who had Stage III Wilms tumor (WT) of favorable histology (FH). Double‐agent chemotherapy was retained for patients with Stage II disea

The treatment of Wilms's tumor

✍ Vincent P. Collins 📂 Article 📅 1958 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB